Gibraltar Capital Management, Inc. Abb Vie Inc. Transaction History

Gibraltar Capital Management, Inc.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$137.62 - $174.96 $3,715 - $4,723	-27 Reduced 0.65%	4,111 $630,000
Q1 2022 Apr 11, 2022	SELL	$131.98 - $163.75 $317,807 - $394,310	-2,408 Reduced 36.79%	4,138 $671,000
Q4 2021 Jan 21, 2022	SELL	$107.43 - $135.93 $221,198 - $279,879	-2,059 Reduced 23.93%	6,546 $886,000
Q3 2021 Oct 13, 2021	SELL	$106.4 - $120.78 $38,729 - $43,963	-364 Reduced 4.06%	8,605 $928,000
Q2 2021 Jul 13, 2021	SELL	$105.21 - $117.21 $4.45 Million - $4.95 Million	-42,267 Reduced 82.49%	8,969 $1.04 Million
Q1 2021 Apr 20, 2021	BUY	$102.3 - $112.62 $813,898 - $896,004	7,956 Added 18.38%	51,236 $5.56 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $137,959 - $186,260	1,714 Added 4.12%	43,280 $4.64 Million
Q3 2020 Nov 05, 2020	BUY	$85.91 - $100.83 $45,188 - $53,036	526 Added 1.28%	41,566 $3.64 Million
Q2 2020 Jul 15, 2020	BUY	$73.37 - $98.18 $101,323 - $135,586	1,381 Added 3.48%	41,040 $4.03 Million
Q1 2020 Apr 16, 2020	BUY	$64.5 - $97.79 $86,946 - $131,820	1,348 Added 3.52%	39,659 $3.02 Million
Q4 2019 Jan 21, 2020	BUY	$72.13 - $90.25 $99,395 - $124,364	1,378 Added 3.73%	38,311 $3.39 Million
Q3 2019 Oct 09, 2019	BUY	$62.98 - $75.72 $284,732 - $342,330	4,521 Added 13.95%	36,933 $2.8 Million
Q2 2019 Jul 17, 2019	BUY	$65.7 - $83.98 $1,248 - $1,595	19 Added 0.06%	32,412 $2.36 Million
Q1 2019 Apr 11, 2019	BUY	$77.14 - $90.79 $2.5 Million - $2.94 Million	32,393 New	32,393 $2.61 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Gibraltar Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Gibraltar Capital Management, Inc. with notifications on news.